Clinical and Laboratory Characteristics of Pediatric Patients With ACKR1/DARC ‐Associated Neutropenia
Pediatric Blood & Cancer · 2025
DOI: 10.1002/pbc.31430 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2025. Verfasst von Lital Oz-Alcalay und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Pediatrics A, Schneider Children's Medical Center of Israel, Petach Tikva, Israel. Hauptthemen laut MEDLINE: Neutropenia, Duffy Blood-Group System, Receptors, Cell Surface. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
ACKR1/DARC‐associated neutropenia (ADAN), resulting from homozygosity for a single nucleotide polymorphism (SNP) in the ACKR1/DARC gene (rs2814778), is a common cause of benign neutropenia that primarily affects individuals of African and Jewish Yemenite descent. We aimed to characterize ADAN in pediatric patients in Israel, given its ethnically diverse population. Procedure We assessed children with isolated neutropenia treated during 2018–2023 at one pediatric center, for the ACKR1/DARC polymorphism, using Sanger sequencing or targeted next‐generation sequencing.
Results
Of 115 patients evaluated, 49 (42.6%) were diagnosed with ADAN; of these, 29 (59%) had absolute neutrophil counts in the severe range (0–0.5 × 10 9 /L) at diagnosis. The allele distribution revealed 37% of Muslim Arab and 61% of Jewish origin. Yemenite, Ethiopian, Mediterranean, Asian, and European ancestry were included; 59% had a family history of neutropenia. The median age at the first neutropenia detection was 1.2 years; 91.8% were identified during routine blood counts. The median absolute neutrophil count at diagnosis was 0.5 × 10 9 /L (interquartile range: 0.3). An increased susceptibility to infections was not found either before or during the median follow‐up period of 2.5 years (interquartile range: 1.54) after the diagnosis of ADAN. In 34 patients (72.3%), neutrophil counts were in the normal range during febrile illnesses.
Conclusions
We identified ADAN in individuals of variable ethnicities, almost half with severe neutropenia. We recommend testing for ADAN in all children with isolated neutropenia without severe infections. Homozygosity for the ACKR1/DARC rs2814778 SNP may obviate the need for further investigation, follow‐up, or treatment in specific clinical scenarios.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Pediatrics A, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
- School of Medicine, Tel Aviv University, Tel Aviv, Israel.
- The Rina Zaizov Hematology/Oncology Division, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
- Pediatric Genetic Unit, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
- Pediatric Hematology Laboratory, Felsenstein Medical Research Center, Petach Tikva, Israel.
ORCID-Profile: Lital Oz-Alcalay, Orna Steinberg-Shemer, Eyal Elron, Sarah Elitzur, Oded Gilad
Zitieren
APA
Oz-Alcalay, L., Steinberg-Shemer, O., Elron, E., Dvori, M., Elitzur, S., Dgany, O., Noy-Lotan, S., Krasnov, T., Tamary, H., Brik-Simon, D., Yacobovich, J., & Gilad, O. (2025). Clinical and Laboratory Characteristics of Pediatric Patients With ACKR1/DARC ‐Associated Neutropenia. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31430
Vancouver
Oz-Alcalay L, Steinberg-Shemer O, Elron E, Dvori M, Elitzur S, Dgany O, et al. Clinical and Laboratory Characteristics of Pediatric Patients With ACKR1/DARC ‐Associated Neutropenia. Pediatric Blood & Cancer. 2025. doi:10.1002/pbc.31430
BibTeX
@article{OzAlcalay2025,
author = {Oz-Alcalay, Lital and Steinberg-Shemer, Orna and Elron, Eyal and Dvori, Michal and Elitzur, Sarah and Dgany, Orly and Noy-Lotan, Sharon and Krasnov, Tanya and Tamary, Hannah and Brik-Simon, Dafna and Yacobovich, Joanne and Gilad, Oded},
title = {Clinical and Laboratory Characteristics of Pediatric Patients With ACKR1/DARC ‐Associated Neutropenia},
journal = {Pediatric Blood & Cancer},
year = {2025},
doi = {10.1002/pbc.31430}
}
EUVIMED